Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. Suspends J&J Covid-19 Vaccine Shipments as States Face a Surplus of Expiring Doses -- 2nd Update

06/10/2021 | 03:25pm EDT

By Jared S. Hopkins and Betsy McKay

The U.S. government has halted new shipments of the Johnson & Johnson Covid-19 vaccine, according to state and federal health officials, one of several steps federal agencies are taking that could help clear a backlog of unused doses before they expire.

The U.S. Centers for Disease Control and Prevention has stopped making available the one-dose shot to states, the state and federal health officials said. The stoppage is believed to be temporary, some of these officials said.

Health officials from Maryland, Oklahoma, Arkansas, Michigan, Illinois and other states said they haven't been able to order new supplies of J&J doses in recent weeks. Some also said they have sufficient supply of the vaccine.

"It just hasn't been included in our weekly allocations, from the feds, which means it is not available to order," said Oklahoma State Department of Health Deputy Commissioner Keith Reed.

The move comes as the U.S. Food and Drug Administration separately extended the shelf life of J&J's vaccine to 4 1/2 months from three months once refrigerated, the drugmaker said Thursday.

It couldn't be determined why the federal government suspended the shipments, but the policy change comes at a time when both federal and state health officials are trying to use up J&J doses that have sat unused so long they are set to expire.

Asked to comment on the government's decision to limit availability of the vaccine to states, a J&J spokesman said, "We continue to work with the U.S. government and health authorities to support the use of our vaccine, which continues to play an important role, including among those who wish to be fully vaccinated with one shot."

Just over half of the approximately 21 million J&J doses distributed in the U.S. have been administered, a lower percentage compared with shots from Pfizer Inc. and Moderna Inc., according to the CDC.

Hospital and state officials said they have many J&J doses expiring later this month, partly as an unintended consequence of the U.S.'s decision in April to temporarily suspend administration of J&J doses to assess a rare blood-clot risk.

The pause forced states and providers to cancel large blocks of appointments that were never rescheduled and left a surplus of supply and, in some areas, increased hesitancy over the J&J vaccine's safety.

The J&J vaccine was authorized by the U.S. Food and Drug Administration in February after researchers found it to be effective in a large-scale trial at protecting against symptomatic Covid-19.

While its efficacy was slightly lower than Pfizer and Moderna shots, public-health officials and vaccine experts had high hopes for the shot's role in the vaccine drive -- because it was a single-shot and required fewer cold-chain restrictions.

J&J stores doses frozen until shipment by the government, at which point they are refrigerated. That is when the countdown starts for expiration.

State health officials said they haven't been able to order new doses of the J&J shot since mid-May. The CDC has been restricting orders of the J&J vaccine, the federal health official said.

A spokeswoman for the Arkansas state health department said it was informed that no doses were available for ordering because of issues related to the manufacturing of the vaccine.

Maryland last ordered J&J doses several weeks ago and has since been told by the government that the vaccine isn't available, Maryland Department of Health Assistant Secretary Bryan Mroz said in an interview. Federal officials say J&J's shot will become available again but didn't say when that would be, he said.

"We've been using up our inventory in the state," Mr. Mroz. "We definitely have more supply than demand."

Mr. Mroz said that some doses will expire at the end of June and others in July and that the state is working to redistribute some to providers who request them.

A Maryland spokesman said Thursday the state would follow the new FDA guidelines extending the vaccine's shelf life. "We are focused on getting as many of the approximately 74,000 J&J doses into as many arms as possible before they expire per the new FDA shelf-life guidelines," he said.

The extended expiration date is likely to help states and providers that have been seeking guidance from the federal government on what to do with the expiring doses.

Thomas M. Burton and Julie Wernau contributed to this article.

Write to Jared S. Hopkins at jared.hopkins@wsj.com and Betsy McKay at betsy.mckay+1@wsj.com

(END) Dow Jones Newswires

06-10-21 1725ET

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL -1.58% 33290.08 Delayed Quote.10.51%
JOHNSON & JOHNSON -1.96% 161.98 Delayed Quote.2.92%
MODERNA, INC. -1.62% 199.19 Delayed Quote.90.67%
PFIZER, INC. -1.70% 38.81 Delayed Quote.5.43%
All news about JOHNSON & JOHNSON
06/19MODERNAá : U.S. administers more than 317 mln doses of COVID-19 vaccines - CDC
RE
06/18The Week Ahead -- Barron's
DJ
06/17JOHNSON & JOHNSONá : Eying border reopening, Mexico begins J&J vaccine rollout i..
AQ
06/17Canada Vaccine Panel Recommends Against AstraZeneca PLC for Second Dose
DJ
06/17US to Spend $3.2 Billion on COVID Treatments Research
MT
06/16ASTRAZENECAá : Second Phase of Covid-19 Vaccinations Begins
AQ
06/16EU Says Johnson & Johnson May Not Meet Vaccine Supply Commitment After Jabs C..
MT
06/15US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..
MT
06/15JOHNSON & JOHNSONá : Aspen to Dispatch 300 000 J&J Vaccines for Teachers
AQ
06/15JOHNSON & JOHNSONá : Donated US vaccines arrive for Mexican border cities
AQ
More news
Financials (USD)
Sales 2021 92 812 M - -
Net income 2021 22 227 M - -
Net Debt 2021 314 M - -
P/E ratio 2021 19,5x
Yield 2021 2,58%
Capitalization 427 B 427 B -
EV / Sales 2021 4,60x
EV / Sales 2022 4,30x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 183,67 $
Last Close Price 161,98 $
Spread / Highest target 25,9%
Spread / Average Target 13,4%
Spread / Lowest Target -2,46%
EPS Revisions
Managers and Directors
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795
ELI LILLY AND COMPANY29.44%198 668